The queried DOI (10.1007/s11095-018-2467-5, a 2018 Pharmaceutical Research article) does not match the supplied evidence, which is for Antioxidants for Prevention of Methionine Oxidation in Recombinant Monoclonal Antibody HER2, DOI 10.1021/js970143s, Journal of Pharmaceutical Sciences, 1997, with 24 references and later citations including 10.1002/jps.22597 . The review below analyzes the paper for which claim-level data was actually supplied. The author list was not included in the supplied record, so author-review links cannot be responsibly generated.
The study's statistical control structure is a strength: four formulations (A–D) differing in NaCl vs mannitol, preservative, and antioxidant; three temperatures (5, 30, 40 °C); light-on vs foil-wrapped; EDTA chelation; nitrogen headspace; and antioxidant titration. Formulation A (NaCl-containing) reached up to 52% oxidized Fc at 40 °C in 2 weeks, and EDTA abolished oxidation — implicating iron from stainless-steel corrosion catalysis; light-induced oxidation ran through singlet oxygen aided by polysorbate 20 . Minimum effective antioxidant ratios were 1:5 (methionine) and 1:25 (thiosulfate); thiosulfate formed an IEC-detectable adduct at 1:100 (6.3 mM, degradation peak a after 2 weeks), whereas methionine (3.5 mM) showed no such degradation .
Critically, despite 48% oxidized Fc in light-exposed, unwrapped Formulation A (vs 16.5% wrapped control), monomer content, antigen (ECD) binding, and BT-474 bioassay activity were largely preserved over the tested interval — meaning the 2-week window could not detect functional consequences of oxidation .
Confidence: high for the reported quantitative findings (directly from the supplied record); moderate for mechanistic generalization beyond rhuMAb HER2.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.